Impact of Pre-Treatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated with Lung Stereotactic Body Radiation Therapy (SBRT)

Interstitial lung disease (ILD) in patients with lung cancer is a management challenge. In this 537 lung SBRT patient study we found that ILD patients (vs non-ILD patients) had greater risk of radiation pneumonitis (RP). On multivariable analysis ILD and mean lung dose were predictors of RP. CT scans should be assessed for ILD before SBRT is considered.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tBXMgv
via IFTTT